Lamotrigine Extended Release Tablets   3

Background
The Defense Logistics Agency (DLA), Directorate of Medical Materiel provides pharmaceutical products for the Department of Defense (DoD) to their customers through the Pharmaceutical Prime Vendor program. The Department of Veterans Affairs (VA) provides pharmaceutical products to their customers as well as the Indian Health Service (IHS) and the Bureau of Prisons (BoP) through the VA Pharmaceutical Prime Vendor Program. Hereafter these programs are collectively referred to as the PPV. A prime vendor is an independent business concern that functions as a purchaser's primary source for specified classes of products and is responsible for the delivery of goods produced by various suppliers. As a part of the Pharmaceutical Prime Vendor Program, this solicitation will establish a national contract for the items listed in the schedule.

Work Details
The contract resulting from this solicitation will establish a national supply source, VA customers through the PPV. The annual usage for DLA, VA, BoP and IHS customers served through the Prime Vendor Programs is estimated in the Schedule of Supplies. The objective of the contract is to ensure availability and consistency of product and to obtain volume-based, committed use pricing. When placing orders with DLA, BoP, IHS or the VA, ordering activities will purchase their requirements from the selected contractor for the items listed in the Schedule of Supplies section of this Solicitation through the DLA or VA prime vendors except when: (1) the contracted items is/are unavailable to meet the needs of or (2) an alternate is requested by the prescribing healthcare provider, or (3) the contract holder does not participate in third party reimbursement programs, such as the Medicaid Rebate Program (#3 applies to IHS requirements only).

Period of Performance
The contract resulting herein will be for a one year base and include four option years for a maximum of five years. The contract will not exceed five years.